Ramius Advisors’s Acceleron Pharma XLRN Stock Holding History

Ramius Advisors’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-24,830	Closed	-$4.27M	–	421
2021 Q3	$4.27M	Buy	+24,830	New	+$3.25M	2.55%	13

Ramius Advisors's XLRN Position: Q4 2021 in Review

Ramius Advisors sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 24,830 shares — an estimated $4.27M sold.

Ramius Advisors first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $4.27M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Ramius Advisors reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Ramius Advisors sold 24,830 Acceleron Pharma shares in Q4 2021, an estimated $4.27M.
Ramius Advisors first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Ramius Advisors's Acceleron Pharma position peaked at $4.27M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Ramius Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.